Substituted indazole analogs
US6040329A · kind A · utility
10Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 5, 1997 |
| Grant date | Mar 21, 2000 |
| Priority date | — |
| Expiry date | Jun 5, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the formula I ##STR1## and pharmaceutically acceptable salts thereof, wherein R, R.sub.1, and R.sub.2, are as defined herein. The invention further relates to pharmaceutical compositions containing, and methods of using, the compounds of formula I, or acceptable salts thereof, for the inhibition of phosphodiesterase (PDE) type IV or the production of tumor necrosis factor (TNF) in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.